Dec 13, 2024
Category
Equity
AUM (Cr.)
254.08
Exit Load (%)
1.00
Min Inv Lumpsum
500
Expense Ratio
0.00
Sharpe Ratio
21.25
Beta Ratio
0.00
Fund Manager
Ramesh Mantri
Inception Date
Feb 06, 2024
Risk Level
Very High
Investment Objective
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. However, there can be no assurance that the investment objective of the Scheme will be realized.